Augustine Therapeutics Revenue and Competitors
Employee Data
- Augustine Therapeutics has 19 Employees.
- Augustine Therapeutics grew their employee count by 58% last year.
Augustine Therapeutics's People
Name | Title | Email/Phone |
---|
Augustine Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 92 | 33% | N/A | N/A |
#2 | N/A | 6 | 0% | N/A | N/A |
#3 | N/A | 19 | 58% | N/A | N/A |
#4 | N/A | 29 | 16% | N/A | N/A |
#5 | N/A | 22 | 29% | N/A | N/A |
#6 | N/A | 14 | -7% | N/A | N/A |
#7 | N/A | 27 | 29% | N/A | N/A |
What Is Augustine Therapeutics?
Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT) and other peripheral neuropathies, neurodegenerative and cardiometabolic disorders. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by Asabys Partners, Eli Lilly and Company, V-Bio Ventures, PMV, AdBio Partners, VIB, Gemma Frisius Fund and CMT Research Foundation.\n \n——— *Disclaimer* ——— \nWe wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.
keywords:N/AN/A
Total Funding
19
Number of Employees
N/A
Revenue (est)
58%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 19 | -10% | N/A |
#2 | $3.5M | 21 | -5% | N/A |
#3 | $3.1M | 22 | -15% | N/A |
#4 | N/A | 23 | 15% | N/A |
#5 | $3.1M | 26 | -69% | N/A |